Can a smarter ventilation setting shield lungs during surgery in obese patients?
NCT ID NCT07774065
First seen Aug 19, 2026 · Last updated Aug 20, 2026 · Updated 1 time
Summary
This trial investigates whether a tailored ventilation strategy during laparoscopic or robotic-assisted surgery can reduce lung complications in obese patients (BMI 35 or higher). The approach uses a higher positive end-expiratory pressure (PEEP) to minimize strain on the lungs during anesthesia. Researchers will measure oxygen levels after surgery and check blood markers for lung injury. The goal is to see if this strategy improves immediate recovery and reduces postoperative pulmonary complications.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- A tailored ventilation strategy using a higher positive end-expiratory pressure (PEEP) to minimize lung strain during surgery
- What this could lead to
- If effective, this ventilation approach could reduce breathing complications and improve recovery for obese patients undergoing laparoscopic surgery.
- What could go wrong
- This is a very small early-stage trial with only 10 participants, so results may not apply broadly. The higher PEEP could also affect blood pressure or heart function during surgery.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 10 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Jul 2026
- Expected to finish
-
Jul 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: 1. Age ≥ 18 years; 2. Body Mass Index (BMI) ≥ 35 kg/m2; 3. Scheduled for laparoscopic surgery expected to exceed 2h (from incision to closure) under general anesthesia, as determined pre-operatively by the attending surgeon and surgical team based on typical scheduling estimates, prior experience, procedure type, planned surgical approach, and patient-specific factors. Exclusion Criteria: 1. Previous lung surgery; 2. Invasive mechanical ventilation for \>30 minutes within the last 30 days prior to surgery; 3. Receipt of immunosuppressive medication (chemotherapy or radiotherapy) up to two months prior to surgery; 4. Neurological procedures or cardiac surgery; 5. Need for one-lung ventilation or planned re-intubation following surgery; 6. Requirement for intraoperative prone or lateral decubitus positioning; 7. Enrollment in another interventional study or refusal to give written informed consent; 8. Pregnancy, determined by anamnesis and/or laboratory testing; 9. Persistent hemodynamic instability or intractable shock, considered hemodynamically unsuitable for the study by the patient's managing physician; 10. Severe chronic obstructive pulmonary disease (COPD, defined as non-invasive ventilation and/or oxygen therapy at home or repeated systemic corticosteroid therapy for acute exacerbations of COPD); 11. Severe cardiac disease (defined as New York Heart Association class III or IV, acute coronary syndrome or persistent ventricular tachyarrhythmia); 12. Acute respiratory distress syndrome (according to the Berlin definition 2) expected to require prolonged postoperative mechanical ventilation; 13. Severe pulmonary arterial hypertension (defined as systolic pulmonary artery pressure \> 40 mmHg) 14. Intracranial injury, intracranial tumor, or neuromuscular disease; 15. Known esophageal disease or anatomy that would preclude the safe placement of a standard orogastric tube
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
University of Texas Medical Branch, Galveston
RECRUITINGGalveston, Texas, 77555, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can shedding pounds reshape the legs? a study tracks joint alignment after Weight-Loss surgery
- Can a diabetes drug restore ovulation in PCOS?
- New pill form of Weight-Loss drug could offer same benefits as capsules
- New pill aims to tackle obesity: early trial tests how the body handles the drug
- Could a Muscle-Building drug boost weight loss? new trial tests bimagrumab with semaglutide
- Strength training and protein diet may reverse frailty in sarcopenic elderly women